JP2015513673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015513673A5 JP2015513673A5 JP2014558962A JP2014558962A JP2015513673A5 JP 2015513673 A5 JP2015513673 A5 JP 2015513673A5 JP 2014558962 A JP2014558962 A JP 2014558962A JP 2014558962 A JP2014558962 A JP 2014558962A JP 2015513673 A5 JP2015513673 A5 JP 2015513673A5
- Authority
- JP
- Japan
- Prior art keywords
- hours
- subject
- serum creatinine
- assigning
- future
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261603926P | 2012-02-27 | 2012-02-27 | |
| US61/603,926 | 2012-02-27 | ||
| PCT/US2013/028005 WO2013130594A1 (en) | 2012-02-27 | 2013-02-27 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015513673A JP2015513673A (ja) | 2015-05-14 |
| JP2015513673A5 true JP2015513673A5 (enExample) | 2016-04-07 |
| JP6538353B2 JP6538353B2 (ja) | 2019-07-03 |
Family
ID=49083234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014558962A Active JP6538353B2 (ja) | 2012-02-27 | 2013-02-27 | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20150050674A1 (enExample) |
| EP (1) | EP2820419B1 (enExample) |
| JP (1) | JP6538353B2 (enExample) |
| CN (1) | CN104335045B (enExample) |
| AU (1) | AU2013226184A1 (enExample) |
| CA (1) | CA2865563A1 (enExample) |
| IN (1) | IN2014MN01760A (enExample) |
| WO (1) | WO2013130594A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016100912A1 (en) | 2014-12-18 | 2016-06-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN105837706A (zh) * | 2016-03-23 | 2016-08-10 | 卞毓平 | 一种甲壳素的提取方法及甲壳素制品 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
| CA2107899A1 (en) | 1991-04-10 | 1992-10-11 | Gunars Edwin Valkirs | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| US7214373B2 (en) * | 2001-07-24 | 2007-05-08 | Yale University | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| ATE493439T1 (de) * | 2005-02-28 | 2011-01-15 | Bio Y As | Monoklonale ykl-40-antikörper |
| US10716749B2 (en) * | 2005-11-03 | 2020-07-21 | Palo Alto Investors | Methods and compositions for treating a renal disease condition in a subject |
| US20100267041A1 (en) * | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
| CN106370857A (zh) * | 2008-10-21 | 2017-02-01 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| US9410968B2 (en) * | 2011-04-04 | 2016-08-09 | Universiteit Gent | Biomarkers for acute kidney injury |
| US20130035290A1 (en) * | 2011-05-17 | 2013-02-07 | Yale University | Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
-
2013
- 2013-02-27 CA CA2865563A patent/CA2865563A1/en not_active Abandoned
- 2013-02-27 JP JP2014558962A patent/JP6538353B2/ja active Active
- 2013-02-27 EP EP13755187.5A patent/EP2820419B1/en active Active
- 2013-02-27 IN IN1760MUN2014 patent/IN2014MN01760A/en unknown
- 2013-02-27 US US14/381,549 patent/US20150050674A1/en not_active Abandoned
- 2013-02-27 WO PCT/US2013/028005 patent/WO2013130594A1/en not_active Ceased
- 2013-02-27 CN CN201380020043.XA patent/CN104335045B/zh active Active
- 2013-02-27 AU AU2013226184A patent/AU2013226184A1/en not_active Abandoned
-
2017
- 2017-05-15 US US15/595,691 patent/US20170248615A1/en not_active Abandoned
-
2018
- 2018-05-16 US US15/981,768 patent/US20180252731A1/en not_active Abandoned
- 2018-12-21 US US16/230,482 patent/US20190120858A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013519095A5 (enExample) | ||
| JP2016505143A5 (enExample) | ||
| JP2014529073A5 (enExample) | ||
| JP2012517594A5 (enExample) | ||
| JP2013510321A5 (enExample) | ||
| Al-Khoury et al. | Anaemia in diabetic patients with chronic kidney disease—prevalence and predictors | |
| JP2013503344A5 (enExample) | ||
| JP2013539861A5 (enExample) | ||
| JP2014521088A5 (enExample) | ||
| JP2012517592A5 (enExample) | ||
| JP2012517593A5 (enExample) | ||
| JP2017533427A5 (enExample) | ||
| Budts et al. | Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology | |
| JP2013531240A5 (enExample) | ||
| Magri et al. | Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism | |
| JP2013515243A5 (enExample) | ||
| Malyszko et al. | Serum neutrophil gelatinase‐associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease | |
| JP2021039112A5 (enExample) | ||
| Ter Maaten et al. | Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure | |
| JP2015129764A5 (enExample) | ||
| Johansson et al. | Acute kidney injury assessed by cystatin C after transcatheter aortic valve implantation and late renal dysfunction | |
| Shen et al. | Acute kidney injury and in-hospital mortality after coronary artery bypass graft versus percutaneous coronary intervention: a nationwide study | |
| Catalano et al. | Incidence of acute kidney injury in patients with chronic renal insufficiency: transcatheter versus surgical aortic valve replacement | |
| Miller | Chronic kidney disease in solid-organ transplantation | |
| JP2017534874A5 (enExample) |